{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T23:08:00Z","timestamp":1789772880471,"version":"4.0.1"},"reference-count":35,"publisher":"American Society of Hematology","issue":"16","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,4,16]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Inherited genetic variants that modulate platelet function contribute significantly to thrombotic disorders, yet their mechanisms and clinical implications remain underexplored. Two genome-wide association studies identified an A\u2192G variant (rs10886430) in the first intron of G protein\u2013coupled receptor kinase 5 (GRK5), found in homozygosity in \u223c5 million Americans. The homozygous GRK5 GG genotype is associated with an increased risk of stroke and venous thromboembolism, but the mechanistic link between this variant and thrombotic risk has remained unclear. To investigate this, we identified 3 GG individuals. GRK5 protein levels in GG platelets were 90% lower than in AA controls. The significant reduction in GRK5 levels in GG platelets led to elevated platelet responsiveness to thrombin and a protease-activated receptor 1 (PAR1) agonist but not a PAR4 agonist. These findings were corroborated in GRK5\u02d7\/\u02d7 induced pluripotent stem cell\u2013derived megakaryocytes, transgenic Grk5-deficient murine platelets, and AA platelets exposed to a GRK5 inhibitor. We demonstrated that PAR1 internalization was reduced in GG platelets, leading to enhanced PAR1 signaling. Under venous shear in an endothelialized microfluidic system, GG platelets exhibited increased accumulation, which was reversed by PAR1 inhibition with vorapaxar. In an arterial murine thrombosis model following human platelet infusion, GG platelets also showed enhanced thrombus formation in vivo. This study provides, to our knowledge, the first experimental evidence directly linking a highly prevalent human GRK5 variant to defective PAR1 regulation and increased thrombotic risk. Together, these findings establish that the GRK5 GG genotype confers increased thrombotic potential through impaired PAR1 desensitization, providing mechanistic insight that connects human genetics, thrombin receptor signaling, and thrombotic disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/blood.2025030223","type":"journal-article","created":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T20:04:46Z","timestamp":1768939486000},"page":"1873-1884","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":5,"title":["Understanding how a highly prevalent\n                    <i>GRK5<\/i>\n                    polymorphism affects platelets and enhances thrombotic risk"],"prefix":"10.1182","volume":"147","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7584-6903","authenticated-orcid":false,"given":"Yanki","family":"Yarman","sequence":"first","affiliation":[{"name":"1Cardeza Foundation of Hematologic Research, Thomas Jefferson University, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8651-6248","authenticated-orcid":false,"given":"Xuefei","family":"Zhao","sequence":"additional","affiliation":[{"name":"1Cardeza Foundation of Hematologic Research, Thomas Jefferson University, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyunsook","family":"Ahn","sequence":"additional","affiliation":[{"name":"2Division of Hematology, Children's Hospital of Philadelphia, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4928-3793","authenticated-orcid":false,"given":"Hannah","family":"Thomson","sequence":"additional","affiliation":[{"name":"1Cardeza Foundation of Hematologic Research, Thomas Jefferson University, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5828-9682","authenticated-orcid":false,"given":"Amrita","family":"Sarkar","sequence":"additional","affiliation":[{"name":"2Division of Hematology, Children's Hospital of Philadelphia, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Yuan","sequence":"additional","affiliation":[{"name":"1Cardeza Foundation of Hematologic Research, Thomas Jefferson University, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan","family":"Roberts","sequence":"additional","affiliation":[{"name":"1Cardeza Foundation of Hematologic Research, Thomas Jefferson University, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy G. T.","family":"Wurtzel","sequence":"additional","affiliation":[{"name":"1Cardeza Foundation of Hematologic Research, Thomas Jefferson University, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott L.","family":"Diamond","sequence":"additional","affiliation":[{"name":"3Department of Chemical and Biomolecular Engineering, Institute for Medicine and Engineering, University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1125-3727","authenticated-orcid":false,"given":"John J. G.","family":"Tesmer","sequence":"additional","affiliation":[{"name":"4Department of Biological Sciences, Purdue University, West Lafayette, IN"},{"name":"5Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, IN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7535-1716","authenticated-orcid":false,"given":"Deborah L.","family":"French","sequence":"additional","affiliation":[{"name":"6Department of Pathology and Laboratory Medicine, Center for Cellular and Molecular Therapeutics, Children\u2019s Hospital of Philadelphia, Philadelphia, PA"},{"name":"7Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Tomaiuolo","sequence":"additional","affiliation":[{"name":"8Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1820-6563","authenticated-orcid":false,"given":"Ernest","family":"Turro","sequence":"additional","affiliation":[{"name":"9Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J.","family":"Astle","sequence":"additional","affiliation":[{"name":"10Medical Research Council Biostatistics Unit, Cambridge Biomedical Campus, University of Cambridge, Cambridge, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0525-6008","authenticated-orcid":false,"given":"Lawrence E.","family":"Goldfinger","sequence":"additional","affiliation":[{"name":"1Cardeza Foundation of Hematologic Research, Thomas Jefferson University, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven E.","family":"McKenzie","sequence":"additional","affiliation":[{"name":"1Cardeza Foundation of Hematologic Research, Thomas Jefferson University, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey L.","family":"Benovic","sequence":"additional","affiliation":[{"name":"11Department of Biochemistry and Molecular Biology, Thomas Jefferson University, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy J.","family":"Stalker","sequence":"additional","affiliation":[{"name":"1Cardeza Foundation of Hematologic Research, Thomas Jefferson University, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mortimer","family":"Poncz","sequence":"additional","affiliation":[{"name":"2Division of Hematology, Children's Hospital of Philadelphia, Philadelphia, PA"},{"name":"12Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5486-8695","authenticated-orcid":false,"given":"Peisong","family":"Ma","sequence":"additional","affiliation":[{"name":"1Cardeza Foundation of Hematologic Research, Thomas Jefferson University, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"3","key":"2026041611214643900_bib1","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.hoc.2013.02.002","article-title":"Harnessing the platelet signaling network to produce an optimal hemostatic response","volume":"27","author":"Brass","year":"2013","journal-title":"Hematol Oncol Clin North Am"},{"issue":"2","key":"2026041611214643900_bib2","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1177\/019262339302100209","article-title":"An overview of hemostasis","volume":"21","author":"Boon","year":"1993","journal-title":"Toxicol Pathol"},{"issue":"6801","key":"2026041611214643900_bib3","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/35025229","article-title":"Thrombin signalling and protease-activated receptors","volume":"407","author":"Coughlin","year":"2000","journal-title":"Nature"},{"issue":"8","key":"2026041611214643900_bib4","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1111\/j.1538-7836.2005.01377.x","article-title":"Protease-activated receptors in hemostasis, thrombosis and vascular biology","volume":"3","author":"Coughlin","year":"2005","journal-title":"J Thromb Haemost"},{"issue":"2","key":"2026041611214643900_bib5","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1182\/blood-2015-11-636472","article-title":"Protease-activated receptors in hemostasis","volume":"128","author":"Nieman","year":"2016","journal-title":"Blood"},{"issue":"2","key":"2026041611214643900_bib6","doi-asserted-by":"crossref","first-page":"156","DOI":"10.5551\/jat.3038","article-title":"Safety and exploratory efficacy of the novel thrombin receptor (PAR-1) antagonist SCH530348 for non-ST-segment elevation acute coronary syndrome","volume":"17","author":"Goto","year":"2010","journal-title":"J Atheroscler Thromb"},{"issue":"15","key":"2026041611214643900_bib7","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1056\/NEJMoa1200933","article-title":"Vorapaxar in the secondary prevention of atherothrombotic events","volume":"366","author":"Morrow","year":"2012","journal-title":"N Engl J Med"},{"issue":"15","key":"2026041611214643900_bib8","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1161\/CIRCULATIONAHA.114.011471","article-title":"Overview of the 2014 Food and Drug Administration Cardiovascular and Renal Drugs Advisory Committee meeting about vorapaxar","volume":"130","author":"Baker","year":"2014","journal-title":"Circulation"},{"issue":"22","key":"2026041611214643900_bib9","first-page":"2675","article-title":"Targeting biased signaling by PAR1: function and molecular mechanism of parmodulins","volume":"141","author":"Kunze","year":"2023","journal-title":"Blood"},{"issue":"8","key":"2026041611214643900_bib10","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.tips.2017.05.001","article-title":"Targeting PAR1: now what?","volume":"38","author":"Flaumenhaft","year":"2017","journal-title":"Trends Pharmacol Sci"},{"issue":"5","key":"2026041611214643900_bib11","doi-asserted-by":"crossref","first-page":"E982","DOI":"10.1073\/pnas.1718600115","article-title":"PAR1 agonists stimulate APC-like endothelial cytoprotection and confer resistance to thromboinflammatory injury","volume":"115","author":"De Ceunynck","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9921","key":"2026041611214643900_bib12","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/S0140-6736(13)61752-3","article-title":"The Framingham heart study and the epidemiology of cardiovascular disease: a historical perspective","volume":"383","author":"Mahmood","year":"2014","journal-title":"Lancet"},{"issue":"8","key":"2026041611214643900_bib13","doi-asserted-by":"crossref","first-page":"e347","DOI":"10.1161\/CIR.0000000000001209","article-title":"2024 heart disease and stroke statistics: a report of US and global data from the American Heart Association","volume":"149","author":"Martin","year":"2024","journal-title":"Circulation"},{"issue":"suppl 1","key":"2026041611214643900_bib14","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1538-7836.2009.03394.x","article-title":"Genetics of venous thrombosis","volume":"7","author":"Rosendaal","year":"2009","journal-title":"J Thromb Haemost"},{"issue":"7","key":"2026041611214643900_bib15","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1182\/bloodadvances.2021005453","article-title":"G protein-coupled receptor kinase 5 regulates thrombin signaling in platelets via PAR-1","volume":"6","author":"Downes","year":"2022","journal-title":"Blood Adv"},{"issue":"2","key":"2026041611214643900_bib16","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ajhg.2020.06.008","article-title":"A platelet function modulator of thrombin activation is causally linked to cardiovascular disease and affects PAR4 receptor signaling","volume":"107","author":"Rodriguez","year":"2020","journal-title":"Am J Hum Genet"},{"issue":"3","key":"2026041611214643900_bib17","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1182\/blood.2022017561","article-title":"RUNX1-deficient human megakaryocytes demonstrate thrombopoietic and platelet half-life and functional defects","volume":"141","author":"Lee","year":"2023","journal-title":"Blood"},{"issue":"1","key":"2026041611214643900_bib18","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1021\/acs.jmedchem.0c01522","article-title":"Generation of highly selective, potent, and covalent G protein-coupled receptor kinase 5 inhibitors","volume":"64","author":"Rowlands","year":"2021","journal-title":"J Med Chem"},{"issue":"5","key":"2026041611214643900_bib19","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/jth.15669","article-title":"Human and mouse PAR4 are functionally distinct receptors: studies in novel humanized mice","volume":"20","author":"Renna","year":"2022","journal-title":"J Thromb Haemost"},{"issue":"1","key":"2026041611214643900_bib20","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1182\/bloodadvances.2019000467","article-title":"GRK6 regulates the hemostatic response to injury through its rate-limiting effects on GPCR signaling in platelets","volume":"4","author":"Chen","year":"2020","journal-title":"Blood Adv"},{"issue":"371","key":"2026041611214643900_bib21","doi-asserted-by":"crossref","first-page":"eaaf5294","DOI":"10.1126\/scitranslmed.aaf5294","article-title":"Blockade of protease-activated receptor-4 (PAR4) provides robust antithrombotic activity with low bleeding","volume":"9","author":"Wong","year":"2017","journal-title":"Sci Transl Med"},{"issue":"15","key":"2026041611214643900_bib22","doi-asserted-by":"crossref","first-page":"4112","DOI":"10.1182\/bloodadvances.2023009661","article-title":"Treatment of thrombocytopenia and thrombosis in HIT in mice using deglycosylated KKO: a novel therapeutic?","volume":"7","author":"Sarkar","year":"2023","journal-title":"Blood Adv"},{"issue":"6","key":"2026041611214643900_bib23","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.thromres.2014.09.030","article-title":"Contact activation of blood coagulation on a defined kaolin\/collagen surface in a microfluidic assay","volume":"134","author":"Zhu","year":"2014","journal-title":"Thromb Res"},{"issue":"6","key":"2026041611214643900_bib24","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1161\/ATVBAHA.112.249789","article-title":"Thrombus growth and embolism on tissue factor-bearing collagen surfaces under flow: role of thrombin with and without fibrin","volume":"32","author":"Colace","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"2026041611214643900_bib25","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1182\/blood.V99.6.1938","article-title":"Incidence of venous thromboembolism in asymptomatic family members who are carriers of factor V Leiden: a prospective cohort study","volume":"99","author":"Simioni","year":"2002","journal-title":"Blood"},{"issue":"6778","key":"2026041611214643900_bib26","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/35007085","article-title":"PAR3 is a cofactor for PAR4 activation by thrombin","volume":"404","author":"Nakanishi-Matsui","year":"2000","journal-title":"Nature"},{"issue":"33","key":"2026041611214643900_bib27","doi-asserted-by":"crossref","first-page":"25216","DOI":"10.1074\/jbc.M004589200","article-title":"Protease-activated receptors 1 and 4 are shut off with distinct kinetics after activation by thrombin","volume":"275","author":"Shapiro","year":"2000","journal-title":"J Biol Chem"},{"issue":"15","key":"2026041611214643900_bib28","doi-asserted-by":"crossref","first-page":"5345","DOI":"10.3390\/ijms21155345","article-title":"The roles of GRKs in hemostasis and thrombosis","volume":"21","author":"Chen","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"18","key":"2026041611214643900_bib29","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.1021\/bi9927078","article-title":"Biphasic kinetics of activation and signaling for PAR1 and PAR4 thrombin receptors in platelets","volume":"39","author":"Covic","year":"2000","journal-title":"Biochemistry"},{"issue":"6","key":"2026041611214643900_bib30","doi-asserted-by":"crossref","first-page":"102556","DOI":"10.1016\/j.rpth.2024.102556","article-title":"G protein-coupled receptor kinase 5 regulates thrombin signaling in platelets","volume":"8","author":"Li","year":"2024","journal-title":"Res Pract Thromb Haemost"},{"issue":"6599","key":"2026041611214643900_bib31","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/383447a0","article-title":"Beta-arrestin acts as a clathrin adaptor in endocytosis of the beta2-adrenergic receptor","volume":"383","author":"Goodman","year":"1996","journal-title":"Nature"},{"issue":"2","key":"2026041611214643900_bib32","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1074\/jbc.M109160200","article-title":"beta -Arrestins regulate protease-activated receptor-1 desensitization but not internalization or Down-regulation","volume":"277","author":"Paing","year":"2002","journal-title":"J Biol Chem"},{"key":"2026041611214643900_bib33","doi-asserted-by":"publisher","DOI":"10.1101\/2023.07.18.549504","article-title":"ACKR3-arrestin 2\/3 complexes reveal molecular consequences of GRK-dependent barcoding","author":"Chen","year":"19  2023","journal-title":"bioRxiv"},{"issue":"45","key":"2026041611214643900_bib34","doi-asserted-by":"crossref","first-page":"16900","DOI":"10.1073\/pnas.0608207103","article-title":"The role of platelet adhesion receptor GPIbalpha far exceeds that of its main ligand, von Willebrand factor, in arterial thrombosis","volume":"103","author":"Bergmeier","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"2026041611214643900_bib35","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1172\/JCI9896","article-title":"Persistence of platelet thrombus formation in arterioles of mice lacking both von Willebrand factor and fibrinogen","volume":"106","author":"Ni","year":"2000","journal-title":"J Clin Invest"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/147\/16\/1873\/2513216\/blood_bld-2025-030223-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/147\/16\/1873\/2513216\/blood_bld-2025-030223-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T15:21:57Z","timestamp":1776352917000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/147\/16\/1873\/566124\/Understanding-how-a-highly-prevalent-GRK5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,16]]},"references-count":35,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2026,4,16]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2025030223","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,4,16]]},"published":{"date-parts":[[2026,4,16]]}}}